RefleXion Medical Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 210
Employees
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $100M
Latest Deal Amount
  • Investors
  • 13

RefleXion Medical General Information

Description

Developer of biology-guided radiotherapy designed to create a new cancer treatment modality. The company's radiotherapy leverages positron emission tomography (PET) in a novel way and combines it with stereotactic radiotherapy for superior localization and tumor tracking at the time of treatment delivery, enabling physicians to reveal cancer cell location and then destroy it.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Primary Office
  • 25841 Industrial Boulevard
  • Suite 275
  • Hayward, CA 94545
  • United States
+1 (650) 000-0000

RefleXion Medical Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RefleXion Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series D) 16-Apr-2020 $100M 00000 00000 Completed Generating Revenue
5. Debt - General 01-May-2019 0000 00000 Completed Generating Revenue
4. Grant 01-Apr-2019 00.000 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 04-Apr-2018 00000 00000 Completed Generating Revenue
2. Later Stage VC (Series B) 19-Jul-2016 $52M $63.6M 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 20-Mar-2014 $11.6M $11.6M 000.00 Completed Startup
To view RefleXion Medical’s complete valuation and funding history, request access »

RefleXion Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 48,199,870 $0.001000 $0.09 $1.08 $1.08 1x $1.08 19.35%
Series A 34,101,874 $0.001000 $0.03 $0.34 $0.34 1x $0.34 13.69%
To view RefleXion Medical’s complete cap table history, request access »

RefleXion Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of biology-guided radiotherapy designed to create a new cancer treatment modality. The company's radiotherapy
Biotechnology
Hayward, CA
210 As of 2021
00000
0000 0000-00-00
00000000000 00000

0-0000

im ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequa
00000000000 0000000
Shilat, Israel
00 As of 0000
0000
0000000000 0 0000

0000

a aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea c
00000000 0000000
San Jose, CA
00 As of 0000
00000
00.00 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RefleXion Medical Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
P-Cure Venture Capital-Backed Shilat, Israel 00 0000 0000000000 0 0000
0000 Formerly VC-backed San Jose, CA 00 00000 000000&0 00000
000000 0000000 000 Private Equity-Backed Littleton, MA 000 00000 0000000 0000 00000
0000000 0000000000 Venture Capital-Backed Cambridge, United Kingdom 0 00.000 0000000000 0 00.000
00000000 00000000 Venture Capital-Backed Morrisville, NC 0 00.000 000000000 - 00.000
You’re viewing 5 of 12 competitors. Get the full list »

RefleXion Medical Executive Team (12)

Name Title Board Seat Contact Info
Samuel Mazin Ph.D Co-Founder, Chief Technology Officer & Board Member
David Larkin Senior Vice President, Research & Development
Calvin Huntzinger Senior Director, Clinical Development
Kathy O'Shaughnessy Ph.D Vice President, Regulatory & Quality Affairs
Todd Powell President, Chief Executive Officer & Board Member
You’re viewing 5 of 12 executive team members. Get the full list »

RefleXion Medical Board Members (13)

Name Representing Role Since
Alice Schroeder Self Board Member 000 0000
Antoine Papiernik Sofinnova Partners Board Member 000 0000
Frederic Moll MD Self Board Member 000 0000
Greg Garfield JD Self Board Member 000 0000
Jay Watkins Self Chairman 000 0000
You’re viewing 5 of 13 board members. Get the full list »

RefleXion Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RefleXion Medical Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Public Sector Pension Investment Board Asset Manager Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
EXOR Seeds Venture Capital Minority 000 0000 000000 0
GT Healthcare Capital Partners Venture Capital Minority 000 0000 000000 0
The Rise Fund Impact Investing Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »